MetLife Inc（MET）の財務METMetLife Inc

MetLife, Inc. (MET) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Group Benefits, accounting for 35.9% of total sales, equivalent to $6.87B. Other significant revenue streams include RIS and Asia. Understanding this composition is critical for investors evaluating how MET navigates market cycles within the Life & Health Insurance industry.

Evaluating the bottom line, MetLife, Inc. maintains a gross margin of N/A. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 6.93%, while the net margin is 4.07%. These profitability ratios, combined with a Return on Equity (ROE) of 12.48%, provide a clear picture of how effectively MET converts its operational activities into shareholder value.

In the context of the broader market, MET competes directly with industry leaders such as SLF and ALL. With a market capitalization of $63.28B, it holds a leading position in the sector. When comparing efficiency, MET's gross margin of N/A stands against SLF's N/A and ALL's N/A. Such benchmarking helps identify whether MetLife, Inc. is trading at a premium or discount relative to its financial performance.

MetLife's forward P/E ratio is 10.54, indicating that the stock is relatively undervalued compared to its earnings potential. The company has demonstrated solid revenue growth, with total revenue expected to reach $23.67 billion in Q4 2025, up from $18.69 billion in Q4 2024.